Atara Biotherapeutics, Inc. · NASDAQ:ATRA

Point72 Asset Management, L.P. reported a 6.20% stake in Atara Biotherapeutics, Inc. (Schedule 13G)

Event May 7, 2026 · Filed May 8, 2026

Point72 Asset Management, L.P. reported a 6.20% stake in Atara Biotherapeutics, Inc., 526,682 shares, as a passive investor on May 7, 2026. Filed May 8, 2026 (Schedule 13G).

Stake
6.20%
Shares
526,682
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.6.20%526,682
Point72 Capital Advisors, Inc.6.20%526,682
Steven A. Cohen6.20%526,682

Source

View original at SEC

Related